LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...
Multi-center, multi-national study builds on existing U.S. PE Clearance and CE Mark to assess mechanical thrombectomy treatment and long-term functional outcomes in intermediate-risk PE patients ...
TEL AVIV-YAFO, Israel — A hospital in Israel is predicting patients’ risk of suffering pulmonary embolism (PE) — a potentially life-threatening lung blockage and the third most common cause of death ...
Early mechanical thrombectomy, within 12 hours of symptom onset, significantly improves patient hemodynamics in acute pulmonary embolism cases. The FLASH registry data support the safety and efficacy ...
A scientific statement regarding disparities in current pulmonary embolism management and outcomes has been published by the AHA. The American Heart Association (AHA) released a scientific statement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback